Abnormal echocardiographic findings after COVID-19 infection : a multicenter registry
© 2022. The Author(s), under exclusive licence to Springer Nature B.V..
The Coronavirus Disease 2019 (COVID-19) pandemic has transformed health systems worldwide. There is conflicting data regarding the degree of cardiovascular involvement following infection. A registry was designed to evaluate the prevalence of echocardiographic abnormalities in adults recovered from COVID-19. We prospectively evaluated 595 participants (mean age 45.5 ± 14.9 years; 50.8% female) from 10 institutions in Argentina and Brazil. Median time between infection and evaluation was two months, and 82.5% of participants were not hospitalized for their infection. Echocardiographic studies were conducted with General Electric equipment; 2DE imaging and global longitudinal strain (GLS) of both ventricles were performed. A total of 61.7% of the participants denied relevant cardiovascular history and 41.8% had prolonged symptoms after resolution of COVID-19 infection. Mean left ventricular ejection fraction (LVEF) was 61.0 ± 5.5% overall. In patients without prior comorbidities, 8.2% had some echocardiographic abnormality: 5.7% had reduced GLS, 3.0% had a LVEF below normal range, and 1.1% had wall motion abnormalities. The right ventricle (RV) was dilated in 1.6% of participants, 3.1% had a reduced GLS, and 0.27% had reduced RV function. Mild pericardial effusion was observed in 0.82% of participants. Male patients were more likely to have new echocardiographic abnormalities (OR 2.82, p = 0.002). Time elapsed since infection resolution (p = 0.245), presence of symptoms (p = 0.927), or history of hospitalization during infection (p = 0.671) did not have any correlation with echocardiographic abnormalities. Cardiovascular abnormalities after COVID-19 infection are rare and usually mild, especially following mild infection, being a low GLS of left and right ventricle, the most common ones in our registry. Post COVID cardiac abnormalities may be more frequent among males.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
The international journal of cardiovascular imaging - 39(2023), 1 vom: 14. Jan., Seite 77-85 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Garcia-Zamora, Sebastián [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 06.01.2023 Date Revised 11.01.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10554-022-02706-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350277478 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350277478 | ||
003 | DE-627 | ||
005 | 20231226044636.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10554-022-02706-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1167.xml |
035 | |a (DE-627)NLM350277478 | ||
035 | |a (NLM)36515755 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Garcia-Zamora, Sebastián |e verfasserin |4 aut | |
245 | 1 | 0 | |a Abnormal echocardiographic findings after COVID-19 infection |b a multicenter registry |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.01.2023 | ||
500 | |a Date Revised 11.01.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature B.V. | ||
520 | |a The Coronavirus Disease 2019 (COVID-19) pandemic has transformed health systems worldwide. There is conflicting data regarding the degree of cardiovascular involvement following infection. A registry was designed to evaluate the prevalence of echocardiographic abnormalities in adults recovered from COVID-19. We prospectively evaluated 595 participants (mean age 45.5 ± 14.9 years; 50.8% female) from 10 institutions in Argentina and Brazil. Median time between infection and evaluation was two months, and 82.5% of participants were not hospitalized for their infection. Echocardiographic studies were conducted with General Electric equipment; 2DE imaging and global longitudinal strain (GLS) of both ventricles were performed. A total of 61.7% of the participants denied relevant cardiovascular history and 41.8% had prolonged symptoms after resolution of COVID-19 infection. Mean left ventricular ejection fraction (LVEF) was 61.0 ± 5.5% overall. In patients without prior comorbidities, 8.2% had some echocardiographic abnormality: 5.7% had reduced GLS, 3.0% had a LVEF below normal range, and 1.1% had wall motion abnormalities. The right ventricle (RV) was dilated in 1.6% of participants, 3.1% had a reduced GLS, and 0.27% had reduced RV function. Mild pericardial effusion was observed in 0.82% of participants. Male patients were more likely to have new echocardiographic abnormalities (OR 2.82, p = 0.002). Time elapsed since infection resolution (p = 0.245), presence of symptoms (p = 0.927), or history of hospitalization during infection (p = 0.671) did not have any correlation with echocardiographic abnormalities. Cardiovascular abnormalities after COVID-19 infection are rare and usually mild, especially following mild infection, being a low GLS of left and right ventricle, the most common ones in our registry. Post COVID cardiac abnormalities may be more frequent among males | ||
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Diagnostic imaging | |
650 | 4 | |a Echocardiography | |
650 | 4 | |a Humans | |
650 | 4 | |a Myocarditis | |
650 | 4 | |a Ventricular remodeling | |
700 | 1 | |a Picco, José M |e verfasserin |4 aut | |
700 | 1 | |a Lepori, Augusto J |e verfasserin |4 aut | |
700 | 1 | |a Galello, Marcela I |e verfasserin |4 aut | |
700 | 1 | |a Saad, Ariel K |e verfasserin |4 aut | |
700 | 1 | |a Ayón, Miguel |e verfasserin |4 aut | |
700 | 1 | |a Monga-Aguilar, Nancy |e verfasserin |4 aut | |
700 | 1 | |a Shehadeh, Issam |e verfasserin |4 aut | |
700 | 1 | |a Manganiello, Carlos F |e verfasserin |4 aut | |
700 | 1 | |a Izaguirre, Cintia |e verfasserin |4 aut | |
700 | 1 | |a Fallabrino, Luciano N |e verfasserin |4 aut | |
700 | 1 | |a Clavero, Matias |e verfasserin |4 aut | |
700 | 1 | |a Mansur, Flavia |e verfasserin |4 aut | |
700 | 1 | |a Ghibaudo, Sebastián |e verfasserin |4 aut | |
700 | 1 | |a Sevilla, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Cado, Cesar A |e verfasserin |4 aut | |
700 | 1 | |a Priotti, Mauricio |e verfasserin |4 aut | |
700 | 1 | |a Liblik, Kiera |e verfasserin |4 aut | |
700 | 1 | |a Gastaldello, Natalio |e verfasserin |4 aut | |
700 | 1 | |a Merlo, Pablo M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The international journal of cardiovascular imaging |d 2001 |g 39(2023), 1 vom: 14. Jan., Seite 77-85 |w (DE-627)NLM113949219 |x 1875-8312 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2023 |g number:1 |g day:14 |g month:01 |g pages:77-85 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10554-022-02706-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2023 |e 1 |b 14 |c 01 |h 77-85 |